In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ritonavir Drug Master File in Korea (Ritonavir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ritonavir. The MFDS reviews the Ritonavir KDMF as part of the drug registration process and uses the information provided in the Ritonavir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ritonavir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ritonavir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ritonavir suppliers with KDMF on PharmaCompass.